article · Frontiers in Pharmacology
EMPA effectively ameliorated DEXA-induced NASH via reducing liver damage caused by excess iron by restoring the appropriate levels of iron, preventing ferroptosis, restoring lipid homeostasis, reducing oxidative stress, and managing inflammation and fibrosis.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3389/fphar.2026.1741926
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
